Evosep | Nordic Capital
Evo Headshot 03

Evosep

Leading innovator in proteomics technologies for the global life science industry

Evosep is a leading Danish innovator of sample preparation and separation solutions for LC-MS-based proteomics. By simplifying complex proteomics processes, Evosep empowers laboratories to deliver deeper biological insights and accelerate discoveries that benefit modern healthcare and life sciences.

Company Background

  • Founded in 2016, Evosep develops sample preparation and separation technologies designed for fast, robust and high-throughput protein analysis in LC-MS-based proteomics.
  • The company produces instruments and consumables that support reproducible proteomics workflows used in translational research and biopharma applications.
  • Evosep works closely with scientists and leading research environments, and its technologies are applied across both academic and biopharma settings.
  • The company aims to make proteomics more accessible by advancing cutting-edge workflows and analytical solutions that simplify complex processes in protein analysis.

Visions & Outlook

  • Accelerate Evosep’s global growth and support its mission to make proteomics more accessible and impactful through cutting-edge workflows, advanced analytics, and actionable insights.
  • Scale Evosep’s platform to meet growing demand for high-performance protein analysis, where consistent and comparable results are critical for biomarker discovery, disease understanding and diagnostic development.
  • Provide strategic support to accelerate product development, strengthen commercial capabilities and further expand Evosep’s presence in the proteomics market.
Evosop White Background

SECTOR

Healthcare

REVENUES 2025

EUR 23 million

EMPLOYEES

c. 80

OWNERSHIP

Nordic Capital Evolution II

INVESTMENT DATE

2025

HEAD OFFICE

Odense, Denmark

MANAGEMENT

Morten Bern

CEO

RESPONSIBLE ADVISOR

Jonas Agnblad

Partner, Co-Head of Evolution advisory

Nordic Capital's healthcare focus

Nordic Capital is one of the most active and experienced investors in healthcare globally, focusing on investments in companies throughout the healthcare space with potential to grow and expand into new markets and industry-leading innovations or value propositions.

Learn more here: